Rick Ryan, Ph.D.
Rick Ryan, Ph.D.
Rick has 30+ years experience in business management and new business/technology development in the life science industry. He has held executive leadership positions in multinational corporations as well as in early stage ventures. He retired from Millipore in December 2010 where he served as Vice President of the Drug Discovery and Development business unit from mid-2006 through 2010. Millipore was acquired by Merck KGaA in mid-2010 and Rick supported several aspects of the integration process with EMD and Serono. Prior to Millipore, Rick was the President of LINCO Research, a company focused on immunoassay kits and services for life science research. LINCO was a leader in the development of multiplex assays for the Luminex platform. Rick started his career in biotechnology/life science at Monsanto where he held several technology and business development positions of increasing responsibility, including Manager, R&D, Director of Commercial/Business Development, Director of Strategic Planning and Director of International Markets. Currently, Rich serves as CEO of Apertus Pharmaceuticals, a new venture focused on the manufacture of high potency API and controlled substances.

Rick received his Ph.D. (Biochemistry) from the University of Illinois and his executive MBA from Washington University in St. Louis. He was an American Cancer Society postdoctoral fellow at the University of Wisconsin. He earned his B.S. in chemistry from Central College in Pella, IA.